Display technologies have evolved considerably over the years, evident just by the fact that manufacturers no longer make CRT or cathode-ray tube monitors, which were bulky and unruly. More recently, ...

The Union Ministry of Home Affairs (MHA) is considering “statutory intervention” in response to a Supreme Court ruling to “progressively reduce” the deputation of Indian Police Service (IPS) officers ...

A Japanese health ministry expert panel has conditionally endorsed two products using iPS cells, paving the way for the world's first practical use of iPS cell-derived products. The panel on Thursday ...

This file photo shows a heart muscle sheet derived from human iPS cells at the University of Osaka in Japan on Jan. 23, 2024. (Kyodo) TOKYO (Kyodo) -- Japan's health ministry panel on Thursday ...

The Rajasthan government transferred 21 Indian Police Service (IPS) officers, including two additional directors general (ADGs), the Jodhpur police commissioner and the Jaipur special commissioner, ...

TOKYO, Feb 19 (Reuters) - Japan's health ministry said on Thursday a panel of specialists had endorsed Sumitomo Pharma's (4506.T), opens new tab iPS cell-derived treatment for Parkinson's disease, ...

A panel of experts on Thursday gave the green light for the health minister to approve the production and sale of two regenerative medical products that use induced pluripotent stem, or iPS, cells.

Add Yahoo as a preferred source to see more of our stories on Google. TOKYO, Feb 19 (Reuters) - Japan's health ministry said on ‌Thursday a panel of ‌specialists had endorsed Sumitomo Pharma's iPS ...

A Japanese health ministry expert panel is to discuss whether to endorse two products using iPS cells. The treatments are for heart disease and Parkinson's. The experts will meet on Thursday evening.

The government has also told the parliament that of the total authorised strength of 15,169 of IAS, IPS and IFS there are 2,834 vacancies. This article went live on February sixteenth, two thousand ...

A health ministry panel has given conditional approval to two medical products derived from iPS cells, paving the way for the world’s first commercialization of Nobel Prize-winning stem cell research.

An expert panel at the health ministry greenlit the domestic manufacturing and marketing of two regenerative medical products that use induced pluripotent stem (iPS) cells on Feb. 19. The health ...